Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,063 public trials 1,834 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity

NCT06620913

Conditions: CV2 Autoimmunity, Lung Diseases, Lung Neoplasms, +5 more
Locations: Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier Est Bron, France

View Trial Details

Active, Not Recruiting

Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences

NCT06616909

Conditions: Advanced Care Planning (ACP), Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Active, Not Recruiting

Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC

NCT06569420

Conditions: ALK-positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Shanghai Pulmonary Hospital Shanghai, China

View Trial Details

Active, Not Recruiting

Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer

NCT05007938

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Feng Ye Xiamen, Fujian, China

View Trial Details

Active, Not Recruiting

Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer

NCT06564870

Conditions: Bronchial Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +7 more
Locations: CHU de Brest Brest, France

View Trial Details

Active, Not Recruiting

Searching for Predictive Biomarkers of Efficacy in Small Cell Lung Cancer Patients Treated With Chemotherapy-immunotherapy Combination Using Imaging Mass Cytometry (HYPE)

NCT06558903

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations: CHU de Brest Brest, France

View Trial Details

Active, Not Recruiting

Research for the Molecular Imaging of the PD-L1 Targeting Tracer

NCT04304066

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
Locations: Shunlian Zhou Beijing, China

View Trial Details

Active, Not Recruiting

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

NCT05867303

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations: ICON Cancer Centre Wesley Auchenflower, Queensland, Australia

Southern Oncology Clinical Research Unit Bedford Park, South Australia, Australia

Cabrini Hospital Malvern Malvern, Victoria, Australia

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer

NCT04685070

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy

NCT03740126

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Rigshospitalet Copenhagen, Denmark

Gentofte Hospital Gentofte Municipality, Denmark

Herlev Hospital Herlev, Denmark

View Trial Details

Respiratory Tract Neoplasms

Respiratory Tract Neoplasms trial results

Related conditions